• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-34a 通过靶向 Fra-1 抑制结肠癌细胞的迁移和侵袭。

MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.

机构信息

Institute of Genomic Medicine, Wenzhou Medical College, 268 Xueyuan Road, Wenzhou, Zhejiang 325000, People's Republic of China.

出版信息

Carcinogenesis. 2012 Mar;33(3):519-28. doi: 10.1093/carcin/bgr304. Epub 2011 Dec 22.

DOI:10.1093/carcin/bgr304
PMID:22198213
Abstract

MicroRNA-34a (miR-34a), a transcriptional target of p53, is a well-known tumor suppressor gene. Here, we identified Fra-1 as a new target of miR-34a and demonstrated that miR-34a inhibits Fra-1 expression at both protein and messenger RNA levels. In addition, we found that p53 indirectly regulates Fra-1 expression via a miR-34a-dependant manner in colon cancer cells. Overexpression of miR-34a strongly inhibited colon cancer cell migration and invasion, which can be partially rescued by forced expression of the Fra-1 transcript lacking the 3'-untranslated region. The expression of matrix metalloproteinase (MMP)-1 and MMP-9, two enzymes involved in cell migration and invasion, was decreased in miR-34a-transfected cells, and this can be rescued by Fra-1 overexpression. Moreover, we found that miR-34a was downregulated in 25 of 40 (62.5%) colon cancer tissues, as compared with the adjacent normal colon tissues and that the expression of miR-34a was correlated with the DNA-binding activity of p53. Unexpectedly, the DNA-binding activity of p53 was not inversely correlated with Fra-1 expression, and a significant statistical inverse correlation between miR-34a and Fra-1 expression was only observed in 14 of 40 (35%) colon cancer tissues. Taken together, our in vitro data suggest that p53 regulates Fra-1 expression, and eventually cell migration/invasion, via a miR-34a-dependent manner. However, in vivo data indicate that the p53-miR-34a pathway is not the major regulator of Fra-1 expression in human colon cancer tissues.

摘要

微小 RNA-34a(miR-34a)是 p53 的转录靶标,是一种众所周知的肿瘤抑制基因。在这里,我们鉴定 Fra-1 是 miR-34a 的一个新靶标,并证明 miR-34a 在蛋白质和信使 RNA 水平上抑制 Fra-1 的表达。此外,我们发现 p53 通过 miR-34a 依赖性方式间接调节结肠癌细胞中 Fra-1 的表达。miR-34a 的过表达强烈抑制结肠癌细胞的迁移和侵袭,而 Fra-1 转录本的 3'-非翻译区缺失的强制表达可部分挽救这种抑制作用。参与细胞迁移和侵袭的两种酶基质金属蛋白酶(MMP)-1 和 MMP-9 的表达在 miR-34a 转染的细胞中降低,而 Fra-1 的过表达可以挽救这种情况。此外,我们发现与相邻的正常结肠组织相比,在 40 个结肠癌组织中的 25 个(62.5%)中下调了 miR-34a 的表达,并且 miR-34a 的表达与 p53 的 DNA 结合活性相关。出乎意料的是,p53 的 DNA 结合活性与 Fra-1 的表达没有呈负相关,并且仅在 40 个结肠癌组织中的 14 个(35%)中观察到 miR-34a 和 Fra-1 表达之间存在显著的统计学负相关。总之,我们的体外数据表明 p53 通过 miR-34a 依赖性方式调节 Fra-1 的表达,进而调节细胞的迁移/侵袭。然而,体内数据表明,p53-miR-34a 途径不是人结肠癌组织中 Fra-1 表达的主要调节因子。

相似文献

1
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.miRNA-34a 通过靶向 Fra-1 抑制结肠癌细胞的迁移和侵袭。
Carcinogenesis. 2012 Mar;33(3):519-28. doi: 10.1093/carcin/bgr304. Epub 2011 Dec 22.
2
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.MicroRNA-34 通过直接靶向 Fra-1 抑制乳腺癌的侵袭和转移。
Oncogene. 2013 Sep 5;32(36):4294-303. doi: 10.1038/onc.2012.432. Epub 2012 Sep 24.
3
MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.微小 RNA-34a:p53 突变型神经胶质瘤细胞系 U251 中的一种新型肿瘤抑制因子。
Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.
4
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.miR-34a对前列腺癌PC3细胞生长和化疗耐药性的影响。
Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1.
5
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.微小RNA-34a通过下调人肝癌细胞中c-Met的表达来抑制细胞迁移和侵袭。
Cancer Lett. 2009 Mar 8;275(1):44-53. doi: 10.1016/j.canlet.2008.09.035. Epub 2008 Nov 8.
6
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.miR-34a的转录激活有助于p53介导的细胞凋亡。
Mol Cell. 2007 Jun 8;26(5):731-43. doi: 10.1016/j.molcel.2007.05.017. Epub 2007 May 31.
7
MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.微小RNA-34a通过下调c-Met抑制葡萄膜黑色素瘤细胞的增殖和迁移。
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1559-65. doi: 10.1167/iovs.08-2681. Epub 2008 Nov 21.
8
MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis.微小 RNA、SND1 和翻译调控改变在结肠癌发生中的作用。
Mutat Res. 2010 Nov 10;693(1-2):94-100. doi: 10.1016/j.mrfmmm.2010.09.001. Epub 2010 Sep 29.
9
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.肿瘤抑制性miR-34a通过调节人结肠癌细胞中的E2F途径诱导衰老样生长停滞。
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7. doi: 10.1073/pnas.0707351104. Epub 2007 Sep 17.
10
MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.微小RNA-195-5p是Fra-1的一种新型调节因子,可抑制前列腺癌细胞的迁移和侵袭。
J Transl Med. 2015 Sep 4;13:289. doi: 10.1186/s12967-015-0650-6.

引用本文的文献

1
Noncoding RNAs as regulators of FOSL1 in cancer.非编码RNA作为癌症中FOSL1的调节因子
Front Immunol. 2025 Aug 1;16:1599674. doi: 10.3389/fimmu.2025.1599674. eCollection 2025.
2
Matrix Dynamics and Microbiome Crosstalk: Matrix Metalloproteinases as Key Players in Disease and Therapy.基质动力学与微生物组相互作用:基质金属蛋白酶在疾病与治疗中的关键作用
Int J Mol Sci. 2025 Apr 11;26(8):3621. doi: 10.3390/ijms26083621.
3
Differential Expression of miRNAs Between Young-Onset and Late-Onset Indian Colorectal Carcinoma Patients.印度早发型和晚发型结直肠癌患者中miRNA的差异表达
Noncoding RNA. 2025 Feb 2;11(1):10. doi: 10.3390/ncrna11010010.
4
Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy.靶向侵袭:基质金属蛋白酶-2和基质金属蛋白酶-9抑制在结直肠癌治疗中的作用
Biomolecules. 2024 Dec 30;15(1):35. doi: 10.3390/biom15010035.
5
Targeted biocompatible Zn-metal-organic framework nanocomposites for intelligent chemotherapy of breast cancer cells.靶向生物相容的 Zn 金属有机骨架纳米复合材料用于乳腺癌细胞的智能化疗。
Sci Rep. 2024 Aug 7;14(1):18311. doi: 10.1038/s41598-024-69457-6.
6
ROS-induced imbalance of the miR-34a-5p/SIRT1/p53 axis triggers chronic chondrocyte injury and inflammation.活性氧诱导的miR-34a-5p/SIRT1/p53轴失衡引发软骨细胞慢性损伤和炎症。
Heliyon. 2024 May 22;10(11):e31654. doi: 10.1016/j.heliyon.2024.e31654. eCollection 2024 Jun 15.
7
FOSL1's Oncogene Roles in Glioma/Glioma Stem Cells and Tumorigenesis: A Comprehensive Review.FOSL1 在神经胶质瘤/神经胶质瘤干细胞和肿瘤发生中的癌基因作用:全面综述。
Int J Mol Sci. 2024 May 14;25(10):5362. doi: 10.3390/ijms25105362.
8
MicroRNA-34 and gastrointestinal cancers: a player with big functions.微小RNA-34与胃肠道癌症:一个功能强大的参与者。
Cancer Cell Int. 2024 May 9;24(1):163. doi: 10.1186/s12935-024-03338-w.
9
Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer.基质金属蛋白酶作为结肠炎相关癌症的生物标志物和治疗靶点。
Front Oncol. 2024 Jan 15;13:1325095. doi: 10.3389/fonc.2023.1325095. eCollection 2023.
10
The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.Fra-1:在调节广泛的免疫细胞状态和影响炎症性疾病中的新作用。
Front Immunol. 2022 Aug 11;13:954744. doi: 10.3389/fimmu.2022.954744. eCollection 2022.